Chemokines, chemokine receptors, and cancer metastasis

Journal of Leukocyte Biology

Volumn 79, Issue 4, 2006, Pages 639-651

  Kakinuma, Takashi ^a   Hwang, Sam T ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Akt; Carcinoma; Melanoma; PI 3K

Indexed keywords

1 [5 CHLORO 2 [2 [4 (4 FLUOROBENZYL) 2 METHYL 1 PIPERAZINYL] 2 OXOETHOXY]PHENYL]UREA; 1 ACETYL N [3 [4 (4 CARBAMOYLBENZYL) 1 PIPERIDINYL]PROPYL] N (3 CHLORO 4 METHYLPHENYL) 4 PIPERIDINECARBOXAMIDE; 1,1' [1,4 PHENYLENEBIS(METHYLENE)]BIS(1,4,8,11 TETRAAZACYCLOTETRADECANE); CCL27 ANTIBODY; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR ANTAGONIST; CHEMOKINE RECEPTOR CCR10; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; CXCL12 CHEMOKINE ANTIBODY; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MACROPHAGE INFLAMMATORY PROTEIN 2; N [4 [[[6,7 DIHYDRO 2 (4 METHYLPHENYL) 5H BENZOCYCLOHEPTEN 8 YL]CARBONYL]AMINO]BENZYL] N,N DIMETHYL 2H TETRAHYDROPYRAN 4 AMINIUM CHLORIDE; NEUTRALIZING ANTIBODY; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN INHIBITOR; PROTEIN KINASE B; TC 14012; TN 14003; ANTINEOPLASTIC AGENT; LIGAND;

ANGIOGENESIS; CELL ADHESION; CELL PROLIFERATION; CELL PROTECTION; DRUG EFFECT; EXTRAVASATION; HUMAN; IMMUNE RESPONSE; LYMPH NODE METASTASIS; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVIEW; TUMOR CELL; TUMOR GROWTH; ANIMAL; DRUG ANTAGONISM; LEUKOCYTE; METABOLISM; NEOPLASM; PHYSIOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; CHEMOKINES; HUMANS; LEUKOCYTES; LIGANDS; NEOPLASM METASTASIS; NEOPLASMS; RECEPTORS, CHEMOKINE;

EID: 33746051169     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1105633     Document Type: Review

References (122)

1. Chambers, A. F., Groom, A. C., MacDonald, I. C. (2002) Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2, 563-572.
2. Steeg, P. S. (2003) Metastasis suppressors alter the signal transduction of cancer cells. Nat. Rev. Cancer 3, 55-63.
3. Vicari, A. P., Caux, C. (2002) Chemokines in cancer. Cytokine Growth Factor Rev. 13, 143-154.
4. Zlotnik, A. (2004) Chemokines in neoplastic progression. Semin. Cancer Biol. 14, 181-185.
5. Murakami, T., Cardones, A. R., Hwang, S. T. (2004) Chemokine receptors and melanoma metastasis. J. Dermatol. Sci. 36, 71-78.
6. Tanaka, T., Bai, Z., Srinoulprasert, Y., Yang, B. G., Hayasaka, H., Miyasaka, M. (2005) Chemokines in tumor progression and metastasis. Cancer Sci. 96, 317-322.
7. Rossi, D., Zlotnik, A. (2000) The biology of chemokines and their receptors. Annu. Rev. Immunol. 18, 217-242.
8. Gerard, C., Rollins, B. J. (2001) Chemokines and disease. Nat. Immunol. 2, 108-115.
9. Zlotnik, A., Yoshie, O. (2000) Chemokines: a new classification system and their role in immunity. Immunity 12, 121-127.
10. Constantin, G., Majeed, M., Giagulli, C., Piccio, L., Kim, J. Y., Butcher, E. C., Laudanna, C. (2000) Chemokines trigger immediate β2 integrin affinity and mobility changes: differential regulation and roles in lymphocyte arrest under flow. Immunity 13, 759-769.
11. Youn, B. S., Yu, K. Y., Oh, J., Lee, J., Lee, T. H., Broxmeyer, H. E. (2002) Role of the CC chemokine receptor 9/TECK interaction in apoptosis. Apoptosis 7, 271-276.
12. Pollard, J. W. (2004) Tumor-educated macrophages promote tumor progression and metastasis. Nat. Rev. Cancer 4, 71-78.
13. Brigati, C., Noonan, D. M., Albini, A., Benelli, R. (2002) Tumors and inflammatory infiltrates: friends or foes? Clin. Exp. Metastasis 19, 247-258.
14. Coussens, L. M., Werb, Z. (2002) Inflammation and cancer. Nature 420, 860-867.
15. Negus, R. P., Stamp, G. W., Hadley, J., Balkwill, F. R. (1997) Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines. Am. J. Pathol. 150, 1723-1734.
16. Negus, R. P., Stamp, G. W., Relf, M. G., Burke, F., Malik, S. T., Bernasconi, S., Allavena, P., Sozzani, S., Mantovani, A., Balkwill, F. R. (1995) The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J. Clin. Invest. 95, 2391-2396.
17. Gu, L., Tseng, S., Horner, R. M., Tam, C., Loda, M., Rollins, B. J. (2000) Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 404, 407-411.
18. Balkwill, F., Mantovani, A. (2001) Inflammation and cancer: back to Virchow? Lancet 357, 539-545.
19. Skinnider, B. F., Mak, T. W. (2002) The role of cytokines in classical Hodgkin lymphoma. Blood 99, 4283-4297.
20. van den Berg, A., Visser, L., Poppema, S. (1999) High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma. Am. J. Pathol. 154, 1685-1691.
21. Vestergaard, C., Deleuran, M., Gesser, B., Gronhoj Larsen, C. (2003) Expression of the T-helper 2-specific chemokine receptor CCR4 on CCR10-positive lymphocytes in atopic dermatitis skin but not in psoriasis skin. Br. J. Dermatol. 149, 457-463.
22. Cosmi, L., Annunziato, F., Maggi, E., Romagnani, S., Manetti, R. (2001) Chemoattractant receptors expressed on type 2 T cells and their role in disease. Int. Arch. Allergy Immunol. 125, 273-279.
23. Sozzani, S., Luini, W., Bianchi, G., Allavena, P., Wells, T. N., Napolitano, M., Bernardini, G., Vecchi, A., D'Ambrosio, D., Mazzeo, D., Sinigaglia, F., Santoni, A., Maggi, E., Romagnani, S., Mantovani, A. (1998) The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant. Blood 92, 4036-4039.
24. Bell, D., Chomarat, P., Broyles, D., Netto, G., Harb, G. M., Lebecque, S., Valladeau, J., Davoust, J., Palucka, K. A., Banchereau, J. (1999) In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J. Exp. Med. 190, 1417-1426.
25. Gavin, M., Rudensky, A. (2003) Control of immune homeostasis by naturally arising regulatory CD4+ T cells. Curr. Opin. Immunol. 15, 690-696.
26. Sakaguchi, S. (2004) Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22, 531-562.
27. Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., Zhu, Y., Wei, S., Kryczek, I., Daniel, B., Gordon, A., Myers, L., Lackner, A., Disis, M. L., Knutson, K. L., Chen, L., Zou, W. (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 10, 942-949.
28. Fontenot, J. D., Rudensky, A. Y. (2005) A well-adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat. Immunol. 6, 331-337.
29. Robinson, S. C., Scott, K. A., Balkwill, F. R. (2002) Chemokine stimulation of monocyte matrix metalloproteinase-9 requires endogenous TNF-α. Eur. J. Immunol. 32, 404-412.
30. Chinni, S. R., Sivalogan, S., Dong, Z., Filho, J. C., Deng, X., Bonfil, R. D., Cher, M. L. (2006) CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment- associated CXCL12. Prostate 66, 32-48.
31. Schadendorf, D., Moller, A., Algermissen, B., Worm, M., Sticherling, M., Czarnetzki, B. M. (1993) IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J. Immunol. 151, 2667-2675.
32. Miyamoto, M., Shimizu, Y., Okada, K., Kashii, Y., Higuchi, K., Watanabe, A. (1998) Effect of interleukin-8 on production of tumor-associated substances and autocrine growth of human liver and pancreatic cancer cells. Cancer Immunol. Immunother. 47, 47-57.
33. Brew, R., Erikson, J. S., West, D. C., Kinsella, A. R., Slavin, J., Christmas, S. E. (2000) Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro. Cytokine 12, 78-85.
34. Dhawan, P., Richmond, A. (2002) Role of CXCL1 in tumorigenesis of melanoma. J. Leukoc. Biol. 72, 9-18.
35. Varney, M. L., Li, A., Dave, B. J., Bucana, C. D., Johansson, S. L., Singh, R. K. (2003) Expression of CXCR1 and CXCR2 receptors in malignant melanoma with different metastatic potential and their role in interleukin-8 (CXCL-8)-mediated modulation of metastatic phenotype. Clin. Exp. Metastasis 20, 723-731.
36. Yang, J., Luan, J., Yu, Y., Li, C., DePinho, R. A., Chin, L., Richmond, A. (2001) Induction of melanoma in murine macrophage inflammatory protein 2 transgenic mice heterozygous for inhibitor of kinase/alternate reading frame. Cancer Res. 61, 8150-8157.
37. Strieter, R. M., Polverini, P. J., Kunkel, S. L., Arenberg, D. A., Burdick, M. D., Kasper, J., Dzuiba, J., Van Damme, J., Walz, A., Marriott, D., et al. (1995) The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J. Biol. Chem. 270, 27348-27357.
38. Belperio, J. A., Keane, M. P., Arenberg, D. A., Addison, C. L., Ehlert, J. E., Burdick, M. D., Strieter, R. M. (2000) CXC chemokines in angiogenesis. J. Leukoc. Biol. 68, 1-8.
39. Strieter, R. M., Belperio, J. A., Burdick, M. D., Sharma, S., Dubinett, S. M., Keane, M. P. (2004) CXC chemokines: angiogenesis, immunoangiostasis, and metastases in lung cancer. Ann. N. Y. Acad. Sci. 1028, 351-360.
40. Arenberg, D. A., Kunkel, S. L., Polverini, P. J., Morris, S. B., Burdick, M. D., Glass, M. C., Taub, D. T., Iannettoni, M. D., Whyte, R. I., Strieter, R. M. (1996) Interferon-γ-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases. J. Exp. Med. 184, 981-992.
41. Salcedo, R., Wasserman, K., Young, H. A., Grimm, M. C., Howard, O. M., Anver, M. R., Kleinman, H. K., Murphy, W. J., Oppenheim, J. J. (1999) Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: in vivo neovascularization induced by stromal-derived factor-1α. Am. J. Pathol. 154, 1125-1135.
42. Guleng, B., Tateishi, K., Ohta, M., Kanai, F., Jazag, A., Ijichi, H., Tanaka, Y., Washida, M., Morikane, K., Fukushima, Y., Yamori, T., Tsuruo, T., Kawabe, T., Miyagishi, M., Taira, K., Sata, M., Omata, M. (2005) Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner. Cancer Res. 65, 5864-5871.
43. Allinen, M., Beroukhim, R., Cai, L., Brennan, C., Lahti-Domenici, J., Huang, H., Porter, D., Hu, M., Chin, L., Richardson, A., Schnitt, S., Sellers, W. R., Polyak, K. (2004) Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6, 17-32.
44. Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., Weinberg, R. A. (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121, 335-348.
45. Barbero, S., Bonavia, R., Bajetto, A., Porcile, C., Pirani, P., Ravetti, J. L., Zona, G. L., Spaziante, R., Florio, T., Schettini, G. (2003) Stromal cell-derived factor 1α stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt. Cancer Res. 63, 1969-1974.
46. Balkwill, F. (2004) Cancer and the chemokine network. Nat. Rev. Cancer 4, 540-550.
47. Muller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., Barrera, J. L., Mohar, A., Verastegui, E., Zlotnik, A. (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410, 50-56.
48. Scotton, C. J., Wilson, J. L., Milliken, D., Stamp, G., Balkwill, F. R. (2001) Epithelial cancer cell migration: a role for chemokine receptors? Cancer Res. 61, 4961-4965.
49. Stein, J. V., Nombela-Arrieta, C. (2005) Chemokine control of lymphocyte trafficking: a general overview. Immunology 116, 1-12.
50. Diaz, G. A., Gulino, A. V. (2005) WHIM syndrome: a defect in CXCR4 signaling. Curr. Allergy Asthma Rep. 5, 350-355.
51. Christopherson II, K. W., Hangoc, G., Broxmeyer, H. E. (2002) Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1 α-mediated chemotaxis of human cord blood CD34+ progenitor cells. J. Immunol. 169, 7000-7008.
52. Luker, K. E., Luker, G. D. (2005) Functions of CXCL12 and CXCR4 in breast cancer. Cancer Lett., E-pub ahead of print.
53. Tachibana, K., Hirota, S., Iizasa, H., Yoshida, H., Kawabata, K., Kataoka, Y., Kitamura, Y., Matsushima, K., Yoshida, N., Nishikawa, S., Kishimoto, T., Nagasawa, T. (1998) The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 393, 591-594.
54. Gunn, M. D., Tangemann, K., Tam, C., Cyster, J. G., Rosen, S. D., Williams, L. T. (1998) A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc. Natl. Acad. Sci. USA 95, 258-263.
55. Saur, D., Seidler, B., Schneider, G., Algul, H., Beck, R., Senekowitsch-Schmidtke, R., Schwaiger, M., Schmid, R. M. (2005) CXCR4 expression increases liver and lung metastasis in a mouse model of pancreatic cancer. Gastroenterology 129, 1237-1250.
56. Murakami, T., Maki, W., Cardones, A. R., Fang, H., Tun Kyi, A., Nestle, F. O., Hwang, S. T. (2002) Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. Cancer Res. 62, 7328-7334.
57. Cardones, A. R., Murakami, T., Hwang, S. T. (2003) CXCR4 enhances adhesion of B16 tumor cells to endothelial cells in vitro and in vivo via β(1) integrin. Cancer Res. 63, 6751-6757.
58. Zhou, Y., Larsen, P. H., Hao, C., Yong, V. W. (2002) CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J. Biol. Chem. 277, 49481-49487.
59. Scotton, C. J., Wilson, J. L., Scott, K., Stamp, G., Wilbanks, G. D., Fricker, S., Bridger, G., Balkwill, F. R. (2002) Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. Cancer Res. 62, 5930-5938.
60. Chen, G. S., Yu, H. S., Lan, C. C., Chow, K. C., Lin, T. Y., Kok, L. F., Lu, M. P., Liu, C. H., Wu, M. T. (2006) CXC chemokine receptor CXCR4 expression enhances tumorigenesis and angiogenesis of basal cell carcinoma. Br. J. Dermatol., in press.
61. Robledo, M. M., Bartolome, R. A., Longo, N., Rodriguez-Frade, J. M., Mellado, M., Longo, I., van Muijen, G. N., Sanchez-Mateos, P., Teixido, J. (2001) Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells. J. Biol. Chem. 276, 45098-45105.
62. Murakami, T., Cardones, A. R., Finkelstein, S. E., Restifo, N. P., Klaunberg, B. A., Nestle, F. O., Castillo, S. S., Dennis, P. A., Hwang, S. T. (2003) Immune evasion by murine melanoma mediated through CC chemokine receptor-10. J. Exp. Med. 198, 1337-1347.
63. Brown, N. S., Bicknell, R. (2001) Hypoxia and oxidative stress in breast cancer. Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer. Breast Cancer Res. 3, 323-327.
64. Knowles, H. J., Harris, A. L. (2001) Hypoxia and oxidative stress in breast cancer. Hypoxia and tumorigenesis. Breast Cancer Res. 3, 318-322.
65. Staller, P., Sulitkova, J., Lisztwan, J., Moch, H., Oakeley, E. J., Krek, W. (2003) Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumor suppressor pVHL. Nature 425, 307-311.
66. Schioppa, T., Uranchimeg, B., Saccani, A., Biswas, S. K., Doni, A., Rapisarda, A., Bernasconi, S., Saccani, S., Nebuloni, M., Vago, L., Mantovani, A., Melillo, G., Sica, A. (2003) Regulation of the chemokine receptor CXCR4 by hypoxia. J. Exp. Med. 198, 1391-1402.
67. Phillips, R. J., Mestas, J., Gharaee-Kermani, M., Burdick, M. D., Sica, A., Belperio, J. A., Keane, M. P., Strieter, R. M. (2005) Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypoxia-inducible factor-1α. J. Biol. Chem. 280, 22473-22481.
68. Li, Y. M., Pan, Y., Wei, Y., Cheng, X., Zhou, B. P., Tan, M., Zhou, X., Xia, W., Hortobagyi, G. N., Yu, D., Hung, M. C. (2004) Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. Cancer Cell 6, 459-469.
69. Nash, K. T., Welch, D. R. (2006) The KISS1 metastasis suppressor: mechanistic insights and clinical utility. Front. Biosci. 11, 647-659.
70. Navenot, J. M., Wang, Z., Chopin, M., Fujii, N., Peiper, S. C. (2005) Kisspeptin-10-induced signaling of GPR54 negatively regulates chemotactic responses mediated by CXCR4: a potential mechanism for the metastasis suppressor activity of kisspeptins. Cancer Res. 65, 10450-10456.
71. Naumov, G. N., MacDonald, I. C., Chambers, A. F., Groom, A. C. (2001) Solitary cancer cells as a possible source of tumor dormancy? Semin. Cancer Biol. 11, 271-276.
72. Weinstat-Saslow, D., Steeg, P. S. (1994) Angiogenesis and colonization in the tumor metastatic process: basic and applied advances. FASEB J. 8, 401-407.
73. Zeelenberg, I. S., Ruuls-Van Stalle, L., Roos, E. (2003) The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res. 63, 3833-3839.
74. Smith, M. C., Luker, K. E., Garbow, J. R., Prior, J. L., Jackson, E., Piwnica-Worms, D., Luker, G. D. (2004) CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res. 64, 8604-8612.
75. Scala, S., Ottaiano, A., Ascierto, P., Cavalli, M., Simeone, E., Giuliano, P., Napolitano, M., Franco, R., Botti, G., Castello, G. (2005) Expression of CXCR4 predicts poor prognosis in patients with maligant melanoma. Clin. Cancer Res. 11, 1835-1841.
76. Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Viale, A., Olshen, A. B., Gerald, W. L., Massague, J. (2005) Genes that mediate breast cancer metastasis to lung. Nature 436, 518-524.
77. Russell, H. V., Hicks, J., Okcu, M. F., Nuchtern, J. G. (2004) CXCR4 expression in neuroblastoma primary tumors is associated with clinical presentation of bone and bone marrow metastases. J. Pediatr. Surg. 39, 1506-1511.
78. Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Kakonen, S. M., Cordon-Cardo, C., Guise, T. A., Massague, J. (2003) A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3, 537-549.
79. Cabioglu, N., Yazici, M. S., Arun, B., Broglio, K. R., Hortobagyi, G. N., Price, J. E., Sahin, A. (2005) CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer. Clin. Cancer Res. 11, 5686-5693.
80. Weigelt, B., Wessels, L. F., Bosma, A. J., Glas, A. M., Nuyten, D. S., He, Y. D., Dai, H., Peterse, J. L., van't Veer, L. J. (2005) No common denominator for breast cancer lymph node metastasis. Br. J. Cancer 93, 924-932.
81. Aiuti, A., Webb, I. J., Bleul, C., Springer, T., Gutierrez-Ramos, J. C. (1997) The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J. Exp. Med. 185, 111-120.
82. Kucia, M., Reca, R., Miekus, K., Wanzeck, J., Wojakowski, W., Janowska-Wieczorek, A., Ratajczak, J., Ratajczak, M. Z. (2005) Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells 23, 879-894.
83. Tomescu, O., Xia, S. J., Strezlecki, D., Bennicelli, J. L., Ginsberg, J., Pawel, B., Barr, F. G. (2004) Inducible short-term and stable long-term cell culture systems reveal that the PAX3-FKHR fusion oncoprotein regulates CXCR4, PAX3, and PAX7 expression. Lab. Invest. 84, 1060-1070.
84. Berk, D. R., Johnson, D. L., Uzieblo, A., Kiernan, M., Swetter, S. M. (2005) Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004. Arch. Dermatol. 141, 1016-1022.
85. Balch, C. M., Soong, S. J., Gershenwald, J. E., Thompson, J. F., Reintgen, D. S., Cascinelli, N., Urist, M., McMasters, K. M., Ross, M. I., Kirkwood, J. M., Atkins, M. B., Thompson, J. A., Coit, D. G., Byrd, D., Desmond, R., Zhang, Y., Liu, P. Y., Lyman, G. H., Morabito, A. (2001) Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J. Clin. Oncol. 19, 3622-3634.
86. Lukas, M., Stossel, H., Hefel, L., Imamura, S., Fritsch, P., Sepp, N. T., Schuler, G., Romani, N. (1996) Human cutaneous dendritic cells migrate through dermal lymphatic vessels in a skin organ culture model. J. Invest. Dermatol. 106, 1293-1299.
87. Saeki, H., Moore, A. M., Brown, M. J., Hwang, S. T. (1999) Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J. Immunol. 162, 2472-2475.
88. Ohl, L., Mohaupt, M., Czeloth, N., Hintzen, G., Kiafard, Z., Zwirner, J., Blankenstein, T., Henning, G., Forster, R. (2004) CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 21, 279-288.
89. Forster, R., Schubel, A., Breitfeld, D., Kremmer, E., Renner-Muller, I., Wolf, E., Lipp, M. (1999) CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99, 23-33.
90. Wiley, H. E., Gonzalez, E. B., Maki, W., Wu, M. T., Hwang, S. T. (2001) Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. J. Natl. Cancer Inst. 93, 1638-1643.
91. Mashino, K., Sadanaga, N., Yamaguchi, H., Tanaka, F., Ohta, M., Shibuta, K., Inoue, H., Mori, M. (2002) Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. Cancer Res. 62, 2937-2941.
92. Takanami, I. (2003) Overexpression of CCR7 mRNA in nonsmall cell lung cancer: correlation with lymph node metastasis. Int. J. Cancer 105, 186-189.
93. Ding, Y., Shimada, Y., Maeda, M., Kawabe, A., Kaganoi, J., Komoto, I., Hashimoto, Y., Miyake, M., Hashida, H., Imamura, M. (2003) Association of CC chemokine receptor 7 with lymph node metastasis of esophageal squamous cell carcinoma. Clin. Cancer Res. 9, 3406-3412.
94. Till, K. J., Lin, K., Zuzel, M., Cawley, J. C. (2002) The chemokine receptor CCR7 and α4 integrin are important for migration of chronic lymphocytic leukemia cells into lymph nodes. Blood 99, 2977-2984.
95. Takeuchi, H., Fujimoto, A., Tanaka, M., Yamano, T., Hsueh, E., Hoon, D. S. (2004) CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells. Clin. Cancer Res. 10, 2351-2358.
96. Giustizieri, M. L., Mascia, F., Frezzolini, A., De Pita, O., Chinni, L. M., Giannetti, A., Girolomoni, G., Pastore, S. (2001) Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines. J. Allergy Clin. Immunol. 107, 871-877.
97. Morales, J., Homey, B., Vicari, A. P., Hudak, S., Oldham, E., Hedrick, J., Orozco, R., Copeland, N. G., Jenkins, N. A., McEvoy, L. M., Zlotnik, A. (1999) CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. Proc. Natl. Acad. Sci. USA 96, 14470-14475.
98. Jarmin, D. I., Rits, M., Bota, D., Gerard, N., Graham, G. J., Lewis, I. C., Gerard, C. (2000) Cutting edge: identification of the orphan receptor G-protein-coupled receptor 2 as CCR10, a specific receptor for the chemokine ESkine. J. Immunol. 164, 3460-3464.
99. Homey, B., Wang, W., Soto, H., Buchanan, M., Wiesenborn, A., Catron, D., Muller, A., McClanahan, T., Nosjean, M. C. D., Orozco, R., Ruzicka, T., Lehmann, P., Oldham, E., Zlotnik, A. (2000) The orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC). J. Immunol. 164, 3465-3470.
100. Reiss, Y., Proudfoot, A. E., Power, C. A., Campbell, J. J., Butcher, E. C. (2001) CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin. J. Exp. Med. 194, 1541-1547.
101. Homey, B., Alenius, H., Muller, A., Soto, H., Bowman, E. P., Yuan, W., McEvoy, L., Lauerma, A. I., Assmann, T., Bunemann, E., Lehto, M., Wolff, H., Yen, D., Marxhausen, H., To, W., Sedgwick, J., Rizicka, T., Lehmann, P., Zlotnik, A. (2002) CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat. Med. 8, 157-165.
102. Vivanco, I., Sawyers, C. L. (2002) The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat. Rev. Cancer 2, 489-501.
103. Notohamiprodjo, M., Segerer, S., Huss, R., Hildebrandt, B., Soler, D., Djafarzadeh, R., Buck, W., Nelson, P. J., von Luettichau, I. (2005) CCR10 is expressed in cutaneous T-cell lymphoma. Int. J. Cancer 115, 641-647.
104. Sokolowska-Wojdylo, M., Wenzel, J., Gaffal, E., Lenz, J., Speuser, P., Erdmann, S., Abuzahra, F., Bowman, E., Roszkiewicz, J., Bieber, T., Tuting, T. (2005) Circulating clonal CLA(+) and CD4(+) T cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7. Br. J. Dermatol. 152, 258-264.
105. Stein, J. V., Rot, A., Luo, Y., Narasimhaswamy, M., Nakano, H., Gunn, M. D., Matsuzawa, A., Dorf, E. J. Q. M. E., von Andrian, U. H. (2000) The CC chemokine thymus-derived chemotactic agent 4 (TCA-4, secondary lymphoid tissue chemokine, 6Ckine, Exodus-2) triggers lymphocyte function-associated antigen 1-mediated arrest of rolling T lymphocytes in peripheral lymph node high endothelial venules. J. Exp. Med. 191, 61-75.
106. Gupta, P. B., Kuperwasser, C., Brunet, J. P., Ramaswamy, S., Kuo, W. L., Gray, J. W., Naber, S. P., Weinberg, R. A. (2005) The melanocyte differentiation program predisposes to metastasis after neoplastic transformation. Nat. Genet. 37, 1047-1054.
107. Kang, H., Watkins, G., Douglas-Jones, A., Mansel, R. E., Jiang, W. G. (2005) The elevated level of CXCR4 is correlated with nodal metastasis of human breast cancer. Breast 14, 360-367.
108. Letsch, A., Keilholz, U., Schadendorf, D., Assfalg, G., Asemissen, A. M., Thiel, E., Scheibenbogen, C. (2004) Functional CCR9 expression is associated with small intestinal metastasis. J. Invest. Dermatol. 122, 685-690.
109. Singh, S., Singh, U. P., Stiles, J. K., Grizzle, W. E., Lillard Jr., J. W. (2004) Expression and functional role of CCR9 in prostate cancer cell migration and invasion. Clin. Cancer Res. 10, 8743-8750.
110. Rubin, J. B., Kung, A. L., Klein, R. S., Chan, J. A., Sun, Y., Schmidt, K., Kieran, M. W., Luster, A. D., Segal, R. A. (2003) A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc. Natl. Acad. Sci. USA 100, 13513-13518.
111. Marchesi, F., Monti, P., Leone, B. E., Zerbi, A., Vecchi, A., Piemonti, L., Mantovani, A., Allavena, P. (2004) Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4. Cancer Res. 64, 8420-8427.
112. Hatse, S., Bridger, G., de Clercq, E., Schols, D. (2003) X4 HIV-1 induces neuroblastoma cell death by interference with CXCL12/CXCR4 interaction. Cell. Mol. Biol. (Noisy-le-grand) 49 (Online Pub), OL443-OL452.
113. Juarez, J., Bradstock, K. F., Gottlieb, D. J., Bendall, L. J. (2003) Effects of inhibitors of the chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro. Leukemia 17, 1294-1300.
114. Liang, Z., Wu, T., Lou, H., Yu, X., Taichman, R. S., Lau, S. K., Nie, S., Umbreit, J., Shim, H. (2004) Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Res. 64, 4302-4308.
115. Mori, T., Doi, R., Koizumi, M., Toyoda, E., Ito, D., Kami, K., Masui, T., Fujimoto, K., Tamamura, H., Hiramatsu, K., Fujii, N., Imamura, M. (2004) CXCR4 antagonist inhibits stromal cell-derived factor 1-induced migration and invasion of human pancreatic cancer. Mol. Cancer Ther. 3, 29-37.
116. Burger, M., Hartmann, T., Krome, M., Rawluk, J., Tamamura, H., Fujii, N., Kipps, T. J., Burger, J. A. (2005) Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells. Blood 106, 1824-1830.
117. Retz, M., Sidhu, S. S., Lehmann, J., Tamamura, H., Fujii, N., Basbaum, C. (2005) New HIV-drug inhibits in vitro bladder cancer migration and invasion. Eur. Urol. 48, 1025-1030.
118. Takenaga, M., Tamamura, H., Hiramatsu, K., Nakamura, N., Yamaguchi, Y., Kitagawa, A., Kawai, S., Nakashima, H., Fujii, N., Igarashi, R. (2004) A single treatment with microcapsules containing a CXCR4 antagonist suppresses pulmonary metastasis of murine melanoma. Biochem. Biophys. Res. Commun. 320, 226-232.
119. Oba, Y., Lee, J. W., Ehrlich, L. A., Chung, H. Y., Jelinek, D. F., Callander, N. S., Horuk, R., Choi, S. J., Roodman, G. D. (2005) MIP-1α utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells. Exp. Hematol. 33, 272-278.
120. Robinson, S. C., Scott, K. A., Wilson, J. L., Thompson, R. G., Proudfoot, A. E., Balkwill, F. R. (2003) A chemokine receptor antagonist inhibits experimental breast tumor growth. Cancer Res. 63, 8360-8365.
121. Vaday, G. G., Peehl, D. M., Kadam, P. A., Lawrence, D. M. (2006) Expression of CCL5 (RANTES) and CCR5 in prostate cancer. Prostate 66, 124-134.
122. Takashima, K., Miyake, H., Kanzaki, N., Tagawa, Y., Wang, X., Sugihara, Y., Iizawa, Y., Baba, M. (2005) Highly potent inhibition of human immunodeficiency virus type 1 replication by TAK-220, an orally bioavailable small-molecule CCR5 antagonist. Antimicrob. Agents Chemother. 49, 3474-3482.